Mingshan Niu
Overview
Explore the profile of Mingshan Niu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng M, Sun S, Feng H, Tan Z, Zhao J, Wu Y, et al.
Eur J Med Chem
. 2024 Oct;
280:116943.
PMID: 39369480
P-glycoprotein (P-gp)-caused multidrug resistance (MDR) is a crucial factor in the cancer chemotherapy failure. Herein, a total of twenty two azo-containing WK-X-34 (WK34, a third generation P-gp inhibitor) derivatives were...
2.
Liu X, Tu Y, Wang Y, Zhou D, Chong Y, Shi L, et al.
Cancer Cell Int
. 2024 Sep;
24(1):320.
PMID: 39294636
No abstract available.
3.
Yao Y, Yuan M, Shi M, Li W, Sha Y, Zhang Y, et al.
Blood Adv
. 2024 May;
8(15):4003-4016.
PMID: 38820414
Because multiple myeloma (MM) poses a formidable therapeutic challenge despite recent progress, exploring novel targets is crucial. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) emerges as a promising paracaspase...
4.
Ma S, Wang Y, Qi K, Lu W, Qi Y, Cao J, et al.
Cancer Immunol Immunother
. 2024 Apr;
73(6):104.
PMID: 38630258
Few studies have reported the associations of granulocyte colony-stimulating factor (G-CSF) with cytokine release syndrome (CRS), neurotoxic events (NEs) and efficacy after chimeric antigen receptor (CAR) T-cell therapy for relapsed...
5.
Liu G, Yu J, Wu R, Shi L, Zhang X, Zhang W, et al.
Cell Death Dis
. 2024 Mar;
15(3):188.
PMID: 38443366
No abstract available.
6.
Liu Y, Yu K, Kong X, Zhang K, Wang L, Zhang N, et al.
Sci Adv
. 2023 Aug;
9(33):eadg7112.
PMID: 37595040
FOXA1, a transcription factor involved in epigenetic reprogramming, is crucial for breast cancer progression. However, the mechanisms by which FOXA1 achieves its oncogenic functions remain elusive. Here, we demonstrate that...
7.
Guo T, Wu C, Zhou L, Zhang J, Wang W, Shen Y, et al.
J Transl Med
. 2023 Aug;
21(1):532.
PMID: 37550679
Background: Glioblastoma (GBM) is a brain tumor with the highest level of malignancy and the worst prognosis in the central nervous system. Mitochondrial metabolism plays a vital role in the...
8.
Wang L, Li G, Zhou Z, Ge C, Chen Q, Liu Y, et al.
Oncogene
. 2023 Jun;
42(30):2329-2346.
PMID: 37353617
Reversible and dynamic O-GlcNAcylation regulates vast networks of highly coordinated cellular and nuclear processes. Although dysregulation of the sole enzyme O-GlcNAc transferase (OGT) was shown to be associated with the...
9.
Yin L, Xu J, Wu W, Niu M, Li Z, Zhu F, et al.
Hematology
. 2023 Jun;
28(1):2224625.
PMID: 37345979
Background: Clinical outcome of patients with chronic myeloid leukemia (CML) has improved dramatically since the introduction of tyrosine kinase inhibitors such as imatinib mesylate (IM). However, approximately 20-30% of patients...
10.
Liu Y, Yu K, Zhang K, Niu M, Chen Q, Liu Y, et al.
EMBO Rep
. 2023 May;
24(7):e56458.
PMID: 37249035
DNA topoisomerase IIα (TOP2A) plays a vital role in replication and cell division by catalytically altering DNA topology. It is a prominent target for anticancer drugs, but clinical efficacy is...